New HD CSF biomarkers informing clinical trials from Dr. Tabrizi Lab

Data from HD-YAS,  a deep-phenotyped longitudinal study of young stages 0 and 1 Huntington’s disease gene expanded (HDGE) individuals, helps to identify predicted clinical motor diagnosis, and biomarkers of disease progression. The study is led by Dr. Sarah Tabrizi at University of College London, who will be coming to speak to the Southern California HD community on February 19th, 4pm. Make sure to register today!

Read the full article here: https://www.nature.com/articles/s41591-024-03424-6

UCI Community Seminar:

Categories: Uncategorized